All Stories
Subscribe to DocCheck AG

DocCheck AG

euro adhoc: DocCheck AG
DocCheck with slightly increased sales in the 1st quarter

  Disclosure announcement transmitted by euro adhoc. The issuer is responsible
  for the content of this announcement.
Cologne, 10th May 2007 - DocCheck AG, Cologne (ISIN DE0005471007 // 
WKN 547100) achieved sales of EUR 3.3 million in the 1st quarter of 
2007, representing growth of 5% over the 1st quarter of 2006 (EUR 3.1
million). Operating income (EBIT), while significantly below the 
previous year´s exceptionally good figure (EUR 328 thousand) at EUR 
38 thousand, is consistent with the long-term trend (1st quarter 
2005: EUR 8 thousand; 1st quarter 2004: EUR 12 thousand). Orders are 
normally lower in the first quarter, as it is marked by the budget 
planning of customers in the healthcare market. It emerged overall in
the 1st quarter that, owing to the changes in the statutory framework
brought about by the major healthcare reform and to the associated 
slight downturn in the pharmaceuticals market, customers in the 
healthcare market reduced their marketing budgets in some areas. 
Particularly affected by this development, which will continue in the
2nd quarter of 2007, was the antwerpes + partner division (agency 
business), which recorded a slight downturn of 7% in sales to EUR 1.6
million. At the same time a clear budget shift towards e-marketing is
evident. This benefits the DocCheck division, comprising the portal 
business, activities in the IP-TV field (DocCheck TV) and syndication
(medicalpicture). Here sales were successfully increased by 33% from 
EUR 0.6 million to EUR 0.7 million.
The DocCheck Shop division, comprising the trading activities, grew 
by 9% from EUR 0.8 million to EUR 0.9 million. The result from normal
business activity is EUR 170 thousand (previous year: EUR 456 
thousand). Earnings per share are 1 cent (previous year: 5 cents). 
The amount held in liquid funds and current-asset securities at the 
end of the 1st quarter was EUR 16.3 million or EUR 2.76 per share 
(previous year: EUR 16.6 million). DocCheck AG aims to increase sales
more significantly in the second quarter.
end of announcement                               euro adhoc 10.05.2007 20:00:00

Further inquiry note:

Tanja Mumme
+49 (0)221 92053 139

Branche: Computing & Information Technology
ISIN: DE0005471007
WKN: 547100
Index: CDAX, Prime All Share, Technologie All Share
Börsen: Frankfurter Wertpapierbörse / regulated dealing/prime
Börse Berlin-Bremen / free trade
Hamburger Wertpapierbörse / free trade
Baden-Württembergische Wertpapierbörse / free trade
Börse Düsseldorf / free trade
Bayerische Börse / free trade

Original content of: DocCheck AG, transmitted by news aktuell

More stories: DocCheck AG
More stories: DocCheck AG